Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryu Watanabe

Showing results (101-110 of 158) with videos related to

Pageof 16
Sort By:
Arthritis Research & Therapy|January 9, 2024
Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohortTakayuki Fujii, Koichi Murata, Hideo Onizawa, et al.
Rheumatology (Oxford, England)|November 21, 2023
Comparative effectiveness of biological disease-modifying antirheumatic drugs and Janus kinase inhibitor monotherapy in rheumatoid arthritisAkira Onishi, Hirotaka Yamada, Wataru Yamamoto, et al.
Annals of the Rheumatic Diseases|February 13, 2018
Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivationMarkus Zeisbrich, Rolando E Yanes, Hui Zhang, et al.
Frontiers in Immunology|October 17, 2024
Long-term efficacy of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: a propensity score matching analysis in the multicenter REVEAL cohort studyMayu Shiomi, Ryu Watanabe, Shogo Matsuda, et al.
Arthritis Research & Therapy|December 20, 2024
Poor prognostic factors for relapse of interstitial lung disease in microscopic polyangiitis: the Japanese multicentre REVEAL cohort studyShogo Matsuda, Takuya Kotani, Ayana Okazaki, et al.
Modern Rheumatology|May 10, 2024
Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort studyMayu Shiomi, Ryu Watanabe, Shogo Matsuda, et al.
The Journal of Clinical Investigation|June 13, 2017
Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunityRyu Watanabe, Tsuyoshi Shirai, Hong Namkoong, et al.
Frontiers in Immunology|June 23, 2022
Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid ArthritisTakeshi Iwasaki, Ryu Watanabe, Hiromu Ito, et al.
Rheumatology (Oxford, England)|January 25, 2022
Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisisHideaki Tsuji, Nobuo Kuramoto, Tsuneo Sasai, et al.
Clinical Rheumatology|September 28, 2021
Perceptions and behaviours related to COVID-19 in patients with rheumatoid arthritis: a cross-sectional studyTakahiro Itaya, Mie Torii, Motomu Hashimoto, et al.
Pageof 16

Showing results (101-110 of 158) with videos related to

Sort By:
Pageof 16
Arthritis Research & Therapy|January 9, 2024
Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohortTakayuki Fujii, Koichi Murata, Hideo Onizawa, et al.
Rheumatology (Oxford, England)|November 21, 2023
Comparative effectiveness of biological disease-modifying antirheumatic drugs and Janus kinase inhibitor monotherapy in rheumatoid arthritisAkira Onishi, Hirotaka Yamada, Wataru Yamamoto, et al.
Annals of the Rheumatic Diseases|February 13, 2018
Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivationMarkus Zeisbrich, Rolando E Yanes, Hui Zhang, et al.
Frontiers in Immunology|October 17, 2024
Long-term efficacy of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: a propensity score matching analysis in the multicenter REVEAL cohort studyMayu Shiomi, Ryu Watanabe, Shogo Matsuda, et al.
Arthritis Research & Therapy|December 20, 2024
Poor prognostic factors for relapse of interstitial lung disease in microscopic polyangiitis: the Japanese multicentre REVEAL cohort studyShogo Matsuda, Takuya Kotani, Ayana Okazaki, et al.
Modern Rheumatology|May 10, 2024
Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort studyMayu Shiomi, Ryu Watanabe, Shogo Matsuda, et al.
The Journal of Clinical Investigation|June 13, 2017
Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunityRyu Watanabe, Tsuyoshi Shirai, Hong Namkoong, et al.
Frontiers in Immunology|June 23, 2022
Dynamics of Type I and Type II Interferon Signature Determines Responsiveness to Anti-TNF Therapy in Rheumatoid ArthritisTakeshi Iwasaki, Ryu Watanabe, Hiromu Ito, et al.
Rheumatology (Oxford, England)|January 25, 2022
Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisisHideaki Tsuji, Nobuo Kuramoto, Tsuneo Sasai, et al.
Clinical Rheumatology|September 28, 2021
Perceptions and behaviours related to COVID-19 in patients with rheumatoid arthritis: a cross-sectional studyTakahiro Itaya, Mie Torii, Motomu Hashimoto, et al.
Pageof 16